Cardiology

Beta-blocker use not linked to reduced mortality after AMI

(HealthDay)—β-blocker use is not associated with reduced mortality after acute myocardial infarction (AMI) without heart failure or left ventricular systolic dysfunction (LVSD), according to a study published in the June ...

Health

USPSTF: evidence lacking for lead screen in kids, pregnancy

(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) has concluded that current evidence is insufficient for assessing the balance of harms and benefits of screening for elevated blood lead levels in asymptomatic ...

Ophthalmology

Measuring eye pressure in glaucoma research using iPerfusion

Researchers at Imperial College London have developed a tool that could change our understanding of one of the eye's critical systems. The results, which were part-funded by Fight for Sight, could make it easier to develop ...

Cardiology

Off-hours presentation not detrimental in STEMI

(HealthDay)—For patients with ST-segment elevation myocardial infarction (STEMI), presentation off-hours seems not to be associated with risk, according to a research letter published online Aug. 30 in the Journal of the ...

Cardiology

Direct admission to PCI center reduces mortality in STEMI

(HealthDay)—For patients with ST-segment elevation myocardial infarction (STEMI) treated with percutaneous coronary intervention (PCI), direct admission to a primary PCI center is associated with lower 12-month mortality, ...

page 5 from 6